Dr. Ciriaco Piccirillo’s Biosketch
Professor, Anna Maria Solinas Laroche Career Award in Immunology
Theme Leader, Translational Immunology, Program in Infectious Disease and Immunity in Global Health (IDIGH)
Director, FOCIS Centre of Excellence in Translational Immunology
Director, Immune Phenotyping Platform
Department of Microbiology & Immunology and Medicine
McGill University and Research Institute of McGill University Health Centre (MUHC)
Centre for Translational Biology Bloc E, Room E-M2.3248
1001 Boulevard Décarie, Montréal, Québec, H4A 3J1
Tel: 514-934-1934 x 76143
Dr. Piccirillo is Professor in the Departments of Microbiology and Immunology, and Medicine of McGill University. He is the nominated Leader for the Translational Immunology theme in the Program in Infectious Diseases and Immunity in Global Health (IDIGH), and Director of FOCIS (Federation of Clinical Immunology Societies) Centre of Excellence in Translational Immunology at McGill and MUHC. He is Senior Scientist and Principal Investigator of the IDIGH Laboratory of Immunoregulation. Finally, he the Director of the ImmunoPhenotyping Platform for the RI-MUHC, a state-of-the-art technological core providing expert advice and training in multi-parametric flow cytometry and cell sorting.
Dr. Piccirillo completed his doctoral training at McGill University in 1998, and then trained at the reputed Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). In 2003, Dr. Piccirillo returned to McGill University to establish his research laboratory.
Dr. Piccirillo is the recipient many distinguished institutional, provincial and international awards which include the CIHR New Investigator Award, FRSQ Chercheur-Boursier Award, and a Tier 2 Canada Research Chair in Regulatory lymphocytes of the Immune System (2004-2014), recipient of the 2012 and 2013 Dr. Phil Gold Fellowship for research excellence, and distinguished 2014 and 2015 Anna Maria Solinas Laroche Career Award in Immunology. He serves on the Board of Directors of FOCIS, and recent founder of the Canadian Human Immunophenotpying Consortium (CHIC).
Dr. Piccirillo leads an internationally recognized research program which focuses on the immune regulation of autoimmune, infectious and inflammatory diseases. His research is responsible for many seminal and pioneering studies related to the phenotype, function and mechanism of action of Foxp3+ regulatory T (Treg) cells in a variety of animal models, non-human primates and humans. His current research program makes use of a variety of mouse models and in human subjects to monitor and characterize the development and functional dynamics of T cell subsets in health and disease. His research program also focuses on the development of novel immunotherapeutic strategies to monitor and manipulate Foxp3+ Treg cell function and ultimately modulate immune responses in infectious, autoimmune and inflammatory disorders.
His laboratory has received research funding from the Canadian Institutes for Health Research, US National Institutes of Health, Canadian Diabetes Association, Juvenile Diabetes Research Foundation, Canadian Foundation of Innovation, and Canada Research Chair program.